11.7 C
Chandigarh
Saturday, January 22, 2022
- Advertisement -
HomeHealthCentral govt to review drug pricing in 10 nations to make medicines...

Central govt to review drug pricing in 10 nations to make medicines inexpensive in India

The target of the analysis is to know the drug pricing methodology adopted within the worldwide market masking a minimum of 10 nations, together with China, Sri Lanka, Bangladesh and the US

Representational picture. Reuters

To make medicine accessible and inexpensive in India, the Narendra Modi authorities is ready to kickstart a research on drug pricing insurance policies of a minimum of 10 nations, together with China, Sri Lanka, Bangladesh and the US, News18.com has realized. The division of prescription drugs (DoP) – beneath the union ministry of chemical compounds and fertilizers – has rolled out a young in quest of a reputed firm that may conduct the research on behalf of the federal government.

The target of the analysis is to know the drug pricing methodology adopted within the worldwide market masking a minimum of 10 nations. It additionally goals to know the teachings realized or one of the best practices from varied nations (or areas) by way of the supply and affordability of medication.

NPPA on the helm

In line with the request for proposal (RFP) doc labelled ‘Notice Inviting Tenders’, accessed by News18.com, drug pricing watchdog Nationwide Prescribed drugs Pricing Authority (NPPA) needs to have interaction reputed companies or analysis establishments for conducting a research. NPPA is an arm of the DoP.

The title of the doc reads “To study the drug pricing policies of different countries/ regions and lessons learned from these countries/ regions in terms of access to medicine at affordable prices”.

The deadline to submit the proposal is February 21, the doc states, whereas shortlisted bidders shall be known as for presentation on 1 March.

Research will contain secondary sources, high 10 nations chosen

The federal government, in line with the doc, plans to review regulatory coverage or framework on drug pricing of a minimum of 10 nations (or areas), to establish greatest practices or classes realized. It additionally plans to review the operational implementation of the drug pricing insurance policies in numerous nations aside from learning different coverage elements that affect the supply and affordability of medication in these nations.

“The minimum ten countries/regions that should be covered are Sri Lanka, Bangladesh, China, EU, UK, Australia, USA, Brazil, South Africa, and Thailand,” the doc states.

The research will primarily be primarily based on secondary sources of information and different data accessible in public area. It additionally entails interviews or focuses group discussions (FGDs) with overseas missions, related commerce and business associations, drug exporters, overseas producers to elicit their suggestions or views.

In line with the 18-page RFP doc, the ultimate report after the collection of the agency needs to be submitted in 4 months. “Besides this, quarterly progress shall be submitted by the applicant till the final submission of the report,” it says.

Learn all of the Newest InformationTrending InformationCricket InformationBollywood Information,
India Information and Leisure Information right here. Observe us on FbTwitter and Instagram.

Supply hyperlink

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular